Joseph Kubiak Jr
Pulmonary Disease · Greenville, SCNPI 1639270598
Payments from drug & device makers
Across 268 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$496
- Boehringer Ingelheim$412
- Electromed, Inc.$395
- AstraZeneca$372
- Jazz Pharmaceuticals Inc.$303
- Philips North America LLC$277
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,39095%
- Education$2335%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 39 | $496 |
| Boehringer Ingelheim | 25 | $412 |
| Electromed, Inc. | 29 | $395 |
| AstraZeneca(2 entities) | 15 | $372 |
| Jazz Pharmaceuticals Inc. | 10 | $303 |
| Philips North America LLC | 12 | $277 |
| Insmed, Inc. | 19 | $267 |
| Mylan Specialty L.p. | 13 | $236 |
| Sunovion Pharmaceuticals Inc. | 14 | $211 |
| Actelion Pharmaceuticals US, Inc. | 11 | $189 |
| Sanofi | 9 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $153 |
| Gilead | 7 | $143 |
| United Therapeutics Corporation | 6 | $137 |
| Grifols USA, LLC | 6 | $100 |
| Johnson & Johnson | 7 | $92 |
| Genentech USA, Inc. | 5 | $83 |
| Harmony Biosciences LLC | 3 | $54 |
| Amgen | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Merck | 3 | $43 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Circassia Inc. | 3 | $40 |
| Shire North American Group Inc | 2 | $38 |
| Resmed Corp | 2 | $37 |
| Bayer | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Advanced Respiratory, Inc | 2 | $24 |
| Optinose US, Inc. | 1 | $22 |
| Vapotherm Inc | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $18 |
| Novartis | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Pulmonx Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$109
How this compares
$4,622 in reported general payments places this provider in the 55th percentile of 192 pulmonary disease providers in South Carolina.
Other pulmonary disease in Greenville
- Sean CallahanGreenville$501K
- Adam SchertzGreenville$54K
- Daniel Lo VerdeGreenville$14K
- Michael KasterGreenville$13K
- Charles FogartySpartanburg$18.7M
- Gregory FeldmanColumbia$15.1M
- Farhan SiddiquiSpartanburg$8.6M
- Joseph BosciaSpartanburg$7.9M
- Charles ThompsonAnderson$7.7M
- David ErbSpartanburg$7.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.